Ardelyx (ARDX) News Today $3.96 +0.24 (+6.30%) Closing price 03:59 PM EasternExtended Trading$3.94 -0.03 (-0.76%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ardelyx, Inc. - ARDXMay 6 at 6:40 PM | prnewswire.comArdelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 ConferenceMay 6 at 8:01 AM | globenewswire.comInsider Selling: Ardelyx, Inc. (NASDAQ:ARDX) CEO Sells 41,666 Shares of StockMay 6 at 4:25 AM | insidertrades.comEquities Analysts Set Expectations for Ardelyx Q4 EarningsMay 6 at 2:59 AM | americanbankingnews.comWedbush Weighs in on Ardelyx's Q4 Earnings (NASDAQ:ARDX)Ardelyx, Inc. (NASDAQ:ARDX - Free Report) - Equities research analysts at Wedbush boosted their Q4 2025 EPS estimates for Ardelyx in a report issued on Friday, May 2nd. Wedbush analyst L. Chico now forecasts that the biopharmaceutical company will post earnings of $0.01 per share for the quarter,May 6 at 2:51 AM | marketbeat.comArdelyx (NASDAQ:ARDX) Shares Down 8.4% After Insider SellingMay 6 at 1:13 AM | americanbankingnews.comScotiabank Remains a Buy on Ardelyx (ARDX)May 5 at 11:07 PM | theglobeandmail.comArdelyx (NASDAQ:ARDX) Announces Earnings ResultsArdelyx (NASDAQ:ARDX - Get Free Report) issued its quarterly earnings results on Thursday. The biopharmaceutical company reported ($0.17) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.07). Ardelyx had a negative return on equity of 24.87% and a negative net margin of 11.73%. The business had revenue of $74.11 million for the quarter, compared to analyst estimates of $79.40 million. During the same quarter last year, the firm earned ($0.11) earnings per share. The firm's quarterly revenue was up 61.1% compared to the same quarter last year.May 5 at 9:24 AM | marketbeat.comHsbc Holdings PLC Acquires New Position in Ardelyx, Inc. (NASDAQ:ARDX)Hsbc Holdings PLC acquired a new stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor acquired 281,764 shares of the biopharmaceutical company's stock, valued at approximately $1,423,0May 5 at 4:14 AM | marketbeat.comCitigroup Issues Pessimistic Forecast for Ardelyx (NASDAQ:ARDX) Stock PriceMay 5 at 3:57 AM | americanbankingnews.comMarshall Wace LLP Takes Position in Ardelyx, Inc. (NASDAQ:ARDX)Marshall Wace LLP bought a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 114,819 shares of the biopharmaceutical compMay 5 at 3:35 AM | marketbeat.comArdelyx (NASDAQ:ARDX) Rating Lowered to "Outperform" at Raymond JamesMay 5 at 2:41 AM | americanbankingnews.comArdelyx (NASDAQ:ARDX) Hits New 1-Year Low Following Weak EarningsArdelyx (NASDAQ:ARDX) Reaches New 52-Week Low Following Weak EarningsMay 4 at 10:20 AM | marketbeat.comArdelyx (NASDAQ:ARDX) Cut to Outperform at Raymond JamesRaymond James lowered Ardelyx from a "strong-buy" rating to an "outperform" rating and set a $11.00 price objective on the stock. in a research note on Friday.May 4 at 8:47 AM | marketbeat.comArdelyx (NASDAQ:ARDX) Reaches New 52-Week Low on Disappointing EarningsMay 4 at 1:23 AM | americanbankingnews.comEarnings call transcript: Ardelyx Inc Q1 2025 sees stock drop after earnings missMay 4 at 12:41 AM | uk.investing.comAnalysts Have Been Trimming Their Ardelyx, Inc. (NASDAQ:ARDX) Price Target After Its Latest ReportMay 3 at 7:41 PM | finance.yahoo.comWells Fargo & Company MN Has $825,000 Stake in Ardelyx, Inc. (NASDAQ:ARDX)Wells Fargo & Company MN decreased its stake in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 49.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 162,656 shares of the biopharmaceutical company's stock after selling 1May 3 at 3:21 AM | marketbeat.comArdelyx downgraded at Raymond James after Q1 sales missMay 2, 2025 | msn.comArdelyx falls 14% as Q1 results miss on both linesMay 2, 2025 | msn.comArdelyx: Revenue Misses And Losses Widen Amid XPHOZAH UncertaintyMay 2, 2025 | seekingalpha.comAdage Capital Partners GP L.L.C. Invests $3.30 Million in Ardelyx, Inc. (NASDAQ:ARDX)Adage Capital Partners GP L.L.C. acquired a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 650,000 shares of the biopharmaceutical company's stockMay 2, 2025 | marketbeat.comArdelyx, Inc. (ARDX) Q1 2025 Earnings Call TranscriptMay 1, 2025 | seekingalpha.comArdelyx Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 1, 2025 | globenewswire.comArdelyx appoints new board member, grants equity awardsMay 1, 2025 | uk.investing.comArdelyx Q1 2025 Earnings PreviewMay 1, 2025 | msn.comArdelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of DirectorsApril 29, 2025 | globenewswire.comPropel Bio Management LLC Decreases Position in Ardelyx, Inc. (NASDAQ:ARDX)Propel Bio Management LLC decreased its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 11.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 950,947 shares of the biopharmacApril 28, 2025 | marketbeat.comJPMorgan Chase & Co. Has $1.19 Million Position in Ardelyx, Inc. (NASDAQ:ARDX)JPMorgan Chase & Co. trimmed its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 39.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 234,667 shares of the biopharmaceutiApril 28, 2025 | marketbeat.comTwo Seas Capital LP Makes New $9.41 Million Investment in Ardelyx, Inc. (NASDAQ:ARDX)Two Seas Capital LP acquired a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 1,855,337 shares of the biopharmaceutical company's stock,April 27, 2025 | marketbeat.com93,764 Shares in Ardelyx, Inc. (NASDAQ:ARDX) Purchased by NatixisNatixis acquired a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 93,764 shares of the biopharmaceutical company's stock, valued at apApril 27, 2025 | marketbeat.comArdelyx (ARDX) Expected to Announce Quarterly Earnings on ThursdayArdelyx (NASDAQ:ARDX) will be releasing its Q1 2025 earnings after the market closes on Thursday, May 1. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-1-ardelyx-inc-stock/)April 26, 2025 | marketbeat.comLPL Financial LLC Has $704,000 Holdings in Ardelyx, Inc. (NASDAQ:ARDX)LPL Financial LLC cut its holdings in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 29.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 138,804 shares of the biopharmaceutical company's stock after sApril 25, 2025 | marketbeat.comArdelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 ConferenceApril 24, 2025 | globenewswire.comRock Springs Capital Management LP Makes New Investment in Ardelyx, Inc. (NASDAQ:ARDX)Rock Springs Capital Management LP purchased a new stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 1,463,629 shares of the biopharmaceutical comApril 23, 2025 | marketbeat.comCreativeOne Wealth LLC Takes $274,000 Position in Ardelyx, Inc. (NASDAQ:ARDX)CreativeOne Wealth LLC purchased a new position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 53,993 shares of the biopharmaceutical company's stock, valued at aApril 22, 2025 | marketbeat.comWedbush Research Analysts Cut Earnings Estimates for ArdelyxArdelyx, Inc. (NASDAQ:ARDX - Free Report) - Wedbush reduced their FY2025 EPS estimates for shares of Ardelyx in a research report issued to clients and investors on Wednesday, April 16th. Wedbush analyst L. Chico now anticipates that the biopharmaceutical company will post earnings per share of (April 20, 2025 | marketbeat.comXTX Topco Ltd Buys 110,514 Shares of Ardelyx, Inc. (NASDAQ:ARDX)XTX Topco Ltd grew its stake in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 369.0% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 140,467 shares of the biopharmaceutical company's stock after acquiring an additional 110,514 shares dApril 20, 2025 | marketbeat.comWedbush Predicts Ardelyx's Q2 Earnings (NASDAQ:ARDX)Ardelyx, Inc. (NASDAQ:ARDX - Free Report) - Stock analysts at Wedbush issued their Q2 2026 EPS estimates for shares of Ardelyx in a report issued on Wednesday, April 16th. Wedbush analyst L. Chico forecasts that the biopharmaceutical company will post earnings per share of $0.01 for the quarter.April 19, 2025 | marketbeat.comCapital Fund Management S.A. Increases Holdings in Ardelyx, Inc. (NASDAQ:ARDX)Capital Fund Management S.A. boosted its position in Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 226.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 313,064 shares of the biopharmaceutical company'sApril 18, 2025 | marketbeat.comArdelyx to Report First Quarter 2025 Financial Results on May 1, 2025April 17, 2025 | globenewswire.comArdelyx, Inc. (NASDAQ:ARDX) Receives Consensus Recommendation of "Buy" from BrokeragesArdelyx, Inc. (NASDAQ:ARDX - Get Free Report) has been assigned an average rating of "Buy" from the ten ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and two have assigneApril 17, 2025 | marketbeat.comIs Ardelyx Inc. (NASDAQ:ARDX) the Best Biotech Penny Stock to Buy According to Hedge Funds?April 16, 2025 | msn.comArdelyx, Inc. (NASDAQ:ARDX) Shares Acquired by Vanguard Group Inc.Vanguard Group Inc. increased its position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 5.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,362,659 shares of the biopharmacApril 13, 2025 | marketbeat.comArdelyx Sees Unusually Large Options Volume (NASDAQ:ARDX)Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) was the recipient of unusually large options trading on Wednesday. Traders bought 12,093 put options on the company. This represents an increase of approximately 411% compared to the typical volume of 2,365 put options.April 11, 2025 | marketbeat.comMichael Raab Sells 41,666 Shares of Ardelyx, Inc. (NASDAQ:ARDX) StockArdelyx, Inc. (NASDAQ:ARDX - Get Free Report) CEO Michael Raab sold 41,666 shares of Ardelyx stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $4.59, for a total transaction of $191,246.94. Following the completion of the transaction, the chief executive officer now directly owns 1,615,587 shares in the company, valued at $7,415,544.33. This trade represents a 2.51 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.April 10, 2025 | marketbeat.comPost-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical MeetingsApril 10, 2025 | globenewswire.comArdelyx (NASDAQ:ARDX) Hits New 12-Month Low - Here's What HappenedArdelyx (NASDAQ:ARDX) Sets New 52-Week Low - Time to Sell?April 9, 2025 | marketbeat.comTrexquant Investment LP Acquires 702,487 Shares of Ardelyx, Inc. (NASDAQ:ARDX)Trexquant Investment LP lifted its holdings in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) by 344.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 906,311 shares of the biopharmaceutical company's stock after purchasing an additionalApril 7, 2025 | marketbeat.comRaymond James Financial Inc. Acquires Shares of 183,490 Ardelyx, Inc. (NASDAQ:ARDX)Raymond James Financial Inc. bought a new position in shares of Ardelyx, Inc. (NASDAQ:ARDX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 183,490 shares of the biopharmaceutical company's stock, vaApril 6, 2025 | marketbeat.com Get Ardelyx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter. Email Address ARDX Media Mentions By Week ARDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARDX News Sentiment▼0.120.69▲Average Medical News Sentiment ARDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARDX Articles This Week▼339▲ARDX Articles Average Week Get Ardelyx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SWTX News Today ZLAB News Today VKTX News Today PTCT News Today CRNX News Today SRRK News Today MRUS News Today CPRX News Today XENE News Today MOR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARDX) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ardelyx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ardelyx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ARDX Stock Free ARDX Stock Alerts